Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · IEX Real-Time Price · USD
6.50
-0.25 (-3.70%)
At close: Nov 27, 2023, 4:00 PM
6.31
-0.19 (-2.92%)
After-hours: Nov 27, 2023, 7:25 PM EST
Centessa Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 stock analysts, the average 12-month stock price forecast for CNTA stock stock is $10, which predicts an increase of 53.85%. The lowest target is $5.00 and the highest is $15. On average, analysts rate CNTA stock stock as a buy.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CNTA stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '23 | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $4 → $11 | Hold → Strong Buy | Upgrades | $4 → $11 | +69.23% | Nov 15, 2023 |
| Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $4 → $8 | Sell → Hold | Upgrades | $4 → $8 | +23.08% | Oct 26, 2023 |
| SVB Securities | SVB Securities | Buy Maintains $6 → $11 | Buy | Maintains | $6 → $11 | +69.23% | Aug 15, 2023 |
| Guggenheim | Guggenheim | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +53.85% | Aug 15, 2023 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $5 → $5 | Hold | Maintains | $5 → $5 | -23.08% | Aug 15, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.89
from -2.31
EPS Next Year
-2.06
from -1.89
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | n/a | n/a | 1.1M | 212.1M | 424.2M |
| Avg | n/a | n/a | 274,890 | 68.3M | 179.3M |
| Low | n/a | n/a | n/a | 1.2M | 34.8M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | - | - | 77,058.1% | 520.8% |
| Avg | - | - | - | 24,757.9% | 162.4% |
| Low | - | - | - | 352.9% | -49.1% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | -1.71 | -1.62 | -1.50 | -1.74 | -1.26 |
| Avg | -1.89 | -2.06 | -1.90 | -1.69 | -1.22 |
| Low | -2.02 | -2.24 | -2.08 | -1.63 | -1.18 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.